Posts in tag

cardiovascular


Debbie Rigby rounds up the latest in research news Efficacy and safety of low-dose colchicine in patients with coronary disease A systematic review and meta-analysis of randomized trials indicates that …

Louis Roller takes a look at high blood pressure: the risks, the causes and the treatments Hypertension (HTN or HT), also known as high blood pressure (HBP), is a long term medical condition in which the blood pressure in the arteries …

The Guild is partnering with Guy Leech and Heart180 to promote defibrillators to community pharmacies  The Pharmacy Guild of Australia has entered into a partnership with Guy Leech Heart180 to promote …

Debbie Rigby rounds up the latest in research news Management of Irritable Bowel Syndrome Irritable bowel syndrome (IBS) is a chronic, often debilitating, and highly prevalent disorder of gut-brain interaction. …

Debbie Rigby takes a look at the latest in research news Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure The EMPEROR-Reduced Trial compared empagliflozin (10 mg once daily) or …

Debbie Rigby takes a look at the latest in research news Omega-3 supplementation and cardiovascular disease Meta-analysis of 17 RCTs shows no association between dose-specific omega-3 supplementation and CVD outcomes. …

Typically, people with cardiovascular disease have one or more comorbid conditions, which challenges treatment and can greatly impact the burden of disease Recent data suggests that more than four million …

Pharmacists can have a key role in atrial fibrillation, particularly in risk management, writes Brad Butt The most prevalent arrhythmia detected in clinical practice is atrial fibrillation (AF) with 2 …

Increasing the use of novel and well-established drugs would offer a significant opportunity to reduce harms caused by diabetes, a new report shows Modelling by the Baker Heart and Diabetes …

Debbie Rigby takes a look at the latest in research news, focusing on COVID-19 A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use …

The Heart Foundation has moved to reassure patients that their heart medicines are in stock and they do not need to worry or stockpile medications It told the general public …

The Heart Foundation says routine use of ARB and ACE inhibitors should continue, after concerns were raised about worse outcomes with COVID-19 newsGP reports that doctors have been querying the …